Invus Public Equities, L.P.
CIK 0001340097
Director10% Owner
Filings
17
Latest Dec 12, 2024
Issuers covered
3
Showing
17 of 17
Page 1
Track record
29 of 29 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 29 | 45% | -3.7% | -9.5% | +31.1% | -55.5% |
| 90 days | 29 | 69% | -13.5% | +3.0% | +106.0% | -129.4% |
| 180 days | 29 | 38% | -3.0% | -9.0% | +83.9% | -52.9% |
| 365 days | 29 | 72% | +48.3% | +42.7% | +228.9% | -71.2% |
Issuers
Companies where Invus Public Equities, L.P. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| CBIO | Crescent Biopharma, Inc. | 8 | Aug 9, 2024 |
| SRRK | Scholar Rock Holding Corp | 6 | Dec 12, 2024 |
| LXRX | Lexicon Pharmaceuticals, Inc. | 3 | May 14, 2024 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|